February 25, 2016
February 25, 2016 – Vancouver, BC, Canada
The Vancouver Sun recently featured Precision NanoSystems in the health section to highlight the NanoAssemblr Platform as the next generation manufacturing platform for nanomedicines.
Randy Shore of the Vancouver Sun writes, “Using the unique physics of fluids at the nano-scale, the NanoAssemblr combines active ingredients — such as therapeutic strands of DNA or RNA — with complementary particles such as fatty molecules to form a kind of armoured transport. The active ingredients are encapsulated until they reach their target.”
Read the full article and view the interview with Precision NanoSystems’ CEO and co-founder, James Taylor.
News Article
Mar 09, 2017
Precision NanoSystems has launched the NanoAssemblr™ Scale-Up system to support the clinical development of nanomedicines. This latest addition to the NanoAssemblr range is designed for the manufacture of clinical trial material in GMP enviro...
Press Release
Feb 23, 2017
Precision NanoSystems is helping scientists to push the boundaries of neuroscience research with a range of efficient and easy-to-use primary cell transfection kits. Combining user-friendly NanoAssemblr™ microfluidics systems with advanced na...